Mechanism of triterpenoids from Alismatis Rhizoma against liver fibrosis based on an integrated approach using network pharmacology, molecular docking, and luciferase assay

被引：0
|
作者：
Zhang, Yi [1 ,2 ,3 ]
Jiang, Kaiyuan [1 ,2 ]
Liu, Pei [1 ,2 ]
Tang, Yingying [1 ,2 ]
Li, Guancheng [4 ]
Xiong, Aizhen [1 ,2 ,3 ]
Yang, Li [1 ,2 ,3 ]
Wang, Zhengtao [1 ,2 ,3 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, SATCM Key Lab New Resources & Qual Evaluat Chinese, Shanghai, Peoples R China
[3] Shanghai R&D Ctr Standardizat Tradit Chinese Med, Shanghai, Peoples R China
[4] Shanghai Univ Tradit Chinese Med, Peoples Hosp 6, Shanghai, Peoples R China
来源：
NATURAL PRODUCT RESEARCH | 2023年 / 37卷 / 22期
关键词：
Alismatis Rhizoma triterpenoids; liver fibrosis; network pharmacology; molecular docking; luciferase assay; farnesoid X receptor; ALISOL B 23-ACETATE; NONALCOHOLIC STEATOHEPATITIS; MEDIATED REGULATION; FXR; TRANSPORTERS; CHOLESTASIS; PROTECTS; ENZYMES; ACID; MICE;
D O I：
10.1080/14786419.2022.2149520
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
Protostane-type triterpenoids are antifibrotic nature components with unique structures in Alismatis Rhizoma. However, the underlying mechanisms of them against liver fibrosis are not well illustrated. The present study aims to study the targets and mechanisms of Alismatis Rhizoma triterpenes responsible for their antifibrotic effects by network pharmacology, molecular docking, and luciferase assay. As a result, six molecular targets responsible for the antifibrotic effects of alisols against liver fibrosis were uncovered by network pharmacology, among which the activation of farnesoid X receptor (FXR/NR1H4) was highlighted and further confirmed by molecular docking and luciferase assay. Our present study provides a scientific basis for treating liver fibrosis by using Alismatis Rhizoma, especially via the FXR activation effects of alisols.
引用
收藏
页码：3826 / 3831
页数：6
相关论文
共 50 条
  • [21] Exploration of the Potential Targets and Molecular Mechanism of Carthamus tinctorius L. for Liver Fibrosis Based on Network Pharmacology and Molecular Docking Strategy
    Hu, Yu
    Lan, Yunxi
    Ran, Qiqi
    Gan, Qianrong
    Tang, Songqi
    Huang, Wei
    PROCESSES, 2022, 10 (09)
  • [22] RETRACTED: Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of Picrorhizae Rhizoma Extract (Retracted Article)
    Hu, Xiaomeng
    Zhao, Shengchao
    Cai, Yi
    Swain, Shasank S.
    Yao, Liangliang
    Liu, Wei
    Yan, Tingdong
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [23] Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking
    Chen, Haixu
    Lin, Yu
    Zeng, Lianlin
    Liu, Shiwei
    MEDICINE, 2022, 101 (51)
  • [24] Exploration of the Mechanism of Tripterygium Wilfordii in the Treatment of Myocardial Fibrosis Based on Network Pharmacology and Molecular Docking
    Ming, Yang
    Jiachen, Liu
    Tao, Guo
    Zhihui, Wang
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2023, 19 (01) : 68 - 79
  • [25] Investigating the Mechanism of Action of Frankincense against Drug-Induced Liver Injury Using Network Pharmacology and Molecular Docking
    Liao, Yu-cheng
    Wang, Jing-wen
    Yang, Qian
    Wang, Wen-jun
    Zhao, Chao
    Sun, Lian
    Wen, Ai-dong
    Li, Rui-li
    Ding, Yi
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (10) : 976 - 986
  • [26] Mechanism of Nardostachyos Radix et Rhizoma–Salidroside in the treatment of premature ventricular beats based on network pharmacology and molecular docking
    Liu Shuyuan
    Chen Haoyu
    Scientific Reports, 13
  • [27] Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification
    Li, Jie
    Wang, Yi
    Wang, Rui
    Wu, Meng-Yu
    Shan, Jing
    Zhang, Ying-Chi
    Xu, Hai-Ming
    HELIYON, 2022, 8 (08)
  • [28] Study on the Mechanism of Acori Graminei Rhizoma in th Treatment of Alzheimer's Disease Based on Network Pharmacology and Molecular Docking
    Du, Yi Kuan
    Xiao, Yue
    Zhong, Shao Min
    Huang, Yi Xing
    Chen, Qian Wen
    Zhou, Yu Qi
    Guo, Jin Yan
    Yang, Chun
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [29] Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation
    Wang, Shou-Jia
    Ye, Wen
    Li, Wan-Yi
    Tian, Wen
    Zhang, Meng
    Sun, Yang
    Feng, Ying-Da
    Liu, Chen-Xu
    Liu, Shao-Yuan
    Cao, Wei
    Meng, Jing-Ru
    Li, Xiao-Qiang
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 303
  • [30] Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
    Zhong, Yanan
    Li, Xiang
    Xie, Juan
    Zhang, Yiyuan
    Li, Hailun
    Zheng, Donghui
    OPEN MEDICINE, 2023, 18 (01):
12345